Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study

What is it about?

Under the condition by strengthening and expanding preventive treatment to high-risk groups as a means to accelerate the decline of TB incidence, LTBI treatment regimens should be systematically evaluated in the settings lacking evidence before being applied in practice. his randomized controlled trial reported that ultra-short latent tuberculosis infection treatment regimen, 6-week twice-weekly rifapentine plus isoniazid, showed balanced safety and protective efficacy in Chinese elderly.

Featured Image